Skip to main content

chemotherapy Archives

A new mode of DNA repair

Apr. 14, 2017—Structural details of a protein that removes DNA lesions shed light on fundamental mechanisms of DNA repair.

Read more


Chemo better option following pancreatic cancer surgery: study

Feb. 25, 2016—A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.

Read more


New lead for ovarian cancer treatment

Dec. 10, 2015—Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer.

Read more


Hach shows age not always a barrier to cancer therapy

Sep. 3, 2015—Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years.

Read more


Study seeks to ease ‘chemobrain’ for cancer patients

Aug. 20, 2015—Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.

Read more


Drug combos enhance ovarian cancer cell death

Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.

Read more


Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

Read more


Dietitian and friends donate chemo care bags to VICC patients

May. 28, 2015—A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients.

Read more


Improving breast cancer chemo by testing tumors in a dish

Oct. 28, 2014—A team of biomedical engineers has developed a new "tumor-in-a-dish" technology that promises to improve the effectiveness of chemotherapy.

Read more


Potential mechanism for myeloma drug’s variable toxicity

Apr. 30, 2014—A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.

Read more


Overcoming resistance in ovarian cancer

Aug. 22, 2013—The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

Read more


Predicting cancer’s response to therapy

Jun. 24, 2013—Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.

Read more


Page 1 of 212

Upcoming Events

MORE EVENTS »